References
Aiello Bowles, E. J., Boudreau, D. M., Chubak, J., Yu, O., Fujii, M., Chestnut, J., & Buist, D. S. (2012). Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer. Journal of Oncology Practice, 8, e149-e157. doi:10.1200/JOP.2012.000543
Amir, E., Seruga, B., Niraula, S., Carlsson, L., & Ocana, A. (2011). Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: A systematic review and meta-analysis. Journal of the National Cancer Institute, 103, 1299-1309. doi:10.1093/jnci/djr242
Baumeister, H., Balke, K., & Harter, M. (2005). Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients. Journal of Clinical Epidemiology, 58, 1090-1100. doi:10.1016/j.jclinepi.2005.03.011
Beekman, A. T., Smit, F., Stek, M. L., Reynolds, C. F., III, & Cuijpers, P. C. (2010). Preventing depression in high-risk groups. Current Opinion in Psychiatry, 23, 8-11. doi:10.1097/YCO.0b013e328333e17f
Bender, C. M., Gentry, A. L., Brufsky, A. M., Casillo, F. E., Cohen, S. M., Dailey, M. M., … Sereika, S. M. (2014). Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancer. Oncology Nursing Forum, 41, 274-285. doi:10.1188/ONF.14.274-285
Blumel, J. E., Castelo-Branco, C., Binfa, L., Gramegna, G., Tacla, X., Aracena, B., … Sanjuan, A. (2000). Quality of life after the menopause: A population study. Maturitas, 34, 17-23.
Burstein, H. J., Prestrud, A. A., Seidenfeld, J., Anderson, H., Buchholz, T. A., Davidson, N. E., … Griggs, J. J. (2010). American Society of Clinical Oncology clinical practice guideline: Update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. Journal of Clinical Oncology, 28, 3784-3796.
Burstein, H. J., Temin, S., Anderson, H., Buchholz, T. A., Davidson, N. E., Gelmon, K. E., … Griggs, J. J. (2014). Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology clinical practice guideline focused update. Journal of Clinical Oncology. Advance online publication. doi:10.1200/JCO.2013.54.2258
Cella, D., Fallowfield, L., Barker, P., Cuzick, J., Locker, G., & Howell, A. (2006). Quality of life of postmenopausal women in the ATAC ("Arimidex," tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer. Breast Cancer Research and Treatment, 100, 273-284. doi:10.1007/s10549-006-9260-6
Chedraui, P., San Miguel, G., & Avila, C. (2009). Quality of life impairment during the female menopausal transition is related to personal and partner factors. Gynecological Endocrinology, 25, 130-135. doi:10.1080/09513590802617770
Christensen, A. J. (2000). Patient-by-treatment context interaction in chronic disease: A conceptual framework for the study of patient adherence. Psychosomatic Medicine, 62, 435-443.
Cluze, C., Rey, D., Huiart, L., Bendiane, M. K., Bouhnik, A. D., Berenger, C., … Giorgi, R. (2011). Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: Determinants of interruptions vary over time. Annals of Oncology, 23, 882-890. doi:10.1093/annonc/mdr330
Conde, D. M., Pinto-Neto, A. M., Cabello, C., Sa, D. S., Costa-Paiva, L., & Martinez, E. Z. (2005). Menopause symptoms and quality of life in women aged 45 to 65 years with and without breast cancer. Menopause, 12, 436-443. doi:10.1097/01.GME.0000151655.10243.48
Cuijpers, P., Beekman, A. T., & Reynolds, C. F., III. (2012). Preventing depression: A global priority. JAMA, 307, 1033-1034. doi:10.1001/jama.2012.271
Davies, C., Pan, H., Godwin, J., Gray, R., Arriagada, R., Raina, V., … Peto, R. (2012). Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet, 9869, 805-816. doi:10.1016/S0140-6736(12)61963-1
Feldman-Stewart, D., Madarnas, Y., Mates, M., Tong, C., Grunfeld, E., Verma, S., … Brundage, M. (2013). Information for decision making by post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy. Breast, 22, 919-925. doi:10.1016/j.breast.2013.04.020
Fink, A. K., Gurwitz, J., Rakowski, W., Guadagnoli, E., & Silliman, R. A. (2004). Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer. Journal of Clinical Oncology, 22, 3309-3315. doi:10.1200/JCO.2004.11.06422/16/3309
Fontein, D. B., Seynaeve, C., Hadji, P., Hille, E. T., van de Water, W., Putter, H., … van de Velde, C. J. (2013). Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: An international tamoxifen exemestane adjuvant multinational trial analysis. Journal of Clinical Oncology, 31, 2257-2264. doi:10.1200/JCO.2012.45.3068
Ganz, P. A., Rowland, J. H., Desmond, K., Meyerowitz, B. E., & Wyatt, G. E. (1998). Life after breast cancer: Understanding women's health-related quality of life and sexual functioning. Journal of Clinical Oncology, 16, 501-514.
Gupta, P., Sturdee, D. W., Palin, S. L., Majumder, K., Fear, R., Marshall, T., & Paterson, I. (2006). Menopausal symptoms in women treated for breast cancer: The prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric, 9, 49-58. doi:10.1080/13697130500487224
Hagan, T. L., & Donovan, H. S. (2013). Ovarian cancer survivors' experiences of self-advocacy: A focus group study. Oncology Nursing Forum, 40, 140-147. doi:10.1188/13.ONF.A12-A19
Henry, N. L., Azzouz, F., Desta, Z., Li, L., Nguyen, A. T., Lemler, S., … Storniolo, A. M. (2012). Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer. Journal of Clinical Oncology, 30, 936-942. doi:10.1200/JCO.2011.38.0261
Hershman, D. L., Kushi, L. H., Shao, T., Buono, D., Kershenbaum, A., Tsai, W. Y., … Neugut, A. I. (2010). Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. Journal of Clinical Oncology, 28, 4120-4128. doi:10.1200/JCO.2009.25.9655
Hershman, D. L., Shao, T., Kushi, L. H., Buono, D., Tsai, W. Y., Fehrenbacher, L., … Neugut, A. I. (2011). Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Research and Treatment, 126, 529-537. doi:10.1007/s10549-010-1132-4
Hickey, M., Saunders, C., Partridge, A., Santoro, N., Joffe, H., & Stearns, V. (2008). Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer. Annals of Oncology, 19, 1669-1680. doi:10.1093/annonc/mdn353
Krebber, A. M., Leemans, C. R., de Bree, R., van Straten, A., Smit, F., Smit, E. F., … Verdonck-de Leeuw, I. M. (2012). Stepped care targeting psychological distress in head and neck and lung cancer patients: A randomized clinical trial. BMC Cancer, 12, 173. doi:10.1186/1471-2407-12-173
Kuzel, A. J. (1992). Sampling in qualitative inquiry. In B. F. Crabtree & W. F. Miller (Eds.), Doing qualitative research. Research methods for primary care (vol. 3, pp. 31-44). Thousand Oaks, CA: Sage.
Land, S. R., Wickerham, D. L., Costantino, J. P., Ritter, M. W., Vogel, V. G., Lee, M., … Ganz, P. A. (2006). Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA, 295, 2742-2751. doi:10.1001/jama.295.23.joc60075
Loh, S. Y., Packer, T., Chinna, K., & Quek, K. F. (2013). Effectiveness of a patient self-management programme for breast cancer as a chronic illness: A non-randomised controlled clinical trial. Journal of Cancer Survivorship, 7, 331-342. doi:10.1007/s11764-013-0274-x
Morse, J. M. (2000). Determining sample size. Qualitative Health Research, 10, 3-5. doi:10.1177/104973200129118183
Morse J. M. (2008) Confusing categories and themes. Qualitative Health Research, 18, 727-728. doi:10.1177/1049732308314930
Motl, R. W., & McAuley, E. (2010). Physical activity, disability, and quality of life in older adults. Physical Medicine and Rehabilitation Clinics of North America, 21, 299-308. doi:10.1016/j.pmr.2009.12.006
Murphy, C. C., Bartholomew, L. K., Carpentier, M. Y., Bluethmann, S. M., & Vernon, S. W. (2012). Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: A systematic review. Breast Cancer Research and Treatment, 134, 459-478. doi:10.1007/s10549-012-2114-5
Partridge, A. H., Wang, P. S., Winer, E. P., & Avorn, J. (2003). Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. Journal of Clinical Oncology, 21, 602-606.
Patton, M. Q. (2002). Qualitative research and evaluation methods. Thousand Oaks, CA: Sage.
Perry, S., Kowalski, T. L., & Chang, C. H. (2007). Quality of life assessment in women with breast cancer: Benefits, acceptability and utilization. Health and Quality of Life Outcomes, 5, 24.
Rechis, R., Boerner, L., Nutt, S., Shaw, K., Berno, D., & Duchover, Y. (2010). How cancer has affected post-treatment survivors: A LiveStrong report. Retrieved from
http://www.livestrong.org/what-we-do/our-approach/reports-findings/how-cancer-has-affected-post-treatment-survivors/
Riegel, B., Moser, D. K., Anker, S. D., Appel, L. J., Dunbar, S. B., Grady, K. L., … Whellan, D. J. (2009). State of the science: Promoting self-care in persons with heart failure: A scientific statement from the American Heart Association. Circulation, 120, 1141-1163.
Ryan, G. W., & Bernard, H. R. (2003). Techniques to identify themes. Field Methods, 15, 85-109. doi:10.1177/1525822x02239569
Schwarz, S., Volzke, H., Alte, D., Schwahn, C., Grabe, H. J., Hoffmann, W., … Doren, M. (2007). Menopause and determinants of quality of life in women at midlife and beyond: The Study of Health in Pomerania (SHIP). Menopause, 14, 123-134. doi:10.1097/01.gme.0000227860.58097.e9
Stanton, A. L., Bernaards, C. A., & Ganz, P. A. (2005). The BCPT symptom scales: A measure of physical symptoms for women diagnosed with or at risk for breast cancer. Journal of the National Cancer Institute, 97, 448-456. doi:10.1093/jnci/dji069
Stearns, V., & Hayes, D. F. (2002). Approach to menopausal symptoms in women with breast cancer. Current Treatment Options in Oncology, 3, 179-190.
Stein, K. D., Jacobsen, P. B., Hann, D. M., Greenberg, H., & Lyman, G. (2000). Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer. Journal of Pain and Symptom Management, 19, 436-445.
Strauss, A. C., & Corbin, J. M. (1990). Basics of qualitative research: Grounded theory procedures and techniques (2nd ed.). Newbury Park, CA: Sage.
van Londen, G., Beckjord, E. B., Dew, M. A., Cuijpers, P., Tadic, S., & Brufsky, A. (2013). Breast cancer survivorship symptom management: Current perspective and future development. Breast Cancer Management, 2, 71-81.
Wilson I. B., & Cleary, P. D. (1995) Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA, 273, 59-65.
Wrosch, C., & Sabiston, C. M. (2012). Goal adjustment, physical and sedentary activity, and well-being and health among breast cancer survivors. Psycho-Oncology, 22, 581-589. doi:10.1002/pon.3037